Bibliography
- Badiani A, Belin D, Epstein D, et al. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 2011;12:685-700
- Sellers EM, Perrino PJ, Colucci SV, et al. Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential. J Psychopharmacol 2013;27:808-16
- Vosburg SK, Jones JD, Manubay JM, et al. A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin (R) (non-TRF) in prescription opioid abusers. Addiction 2013;108:1095-106
- Alexander L, Mannion RO, Weingarten B, et al. Development and impact of prescription opioid abuse deterrent formulation technologies. Drug Alcohol Depend 2014;138:1-6
- Toll L, Khroyan TV, Polgar WE, et al. Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications. J Pharmacol Exp Ther 2009;331:954-64
- Rush CR, Stoops WW. Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem 2012;4:245-65
- Tomek SE, LaCrosse AL, Nemirovsky NE, et al. NMDA receptor modulators in the treatment of drug addiction. Pharmaceuticals (Basel) 2013;6:251-68
- Rutten K, De Vry J, Bruckmann W, et al. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats. Eur J Pharmacol 2010;645:119-26
- Zaveri NT. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem 2011;11:1151-6
- Ahmed SH. The science of making drug-addicted animals. Neuroscience 2012;211:107-25
- Stephens DN, Crombag HS, Duka T. The challenge of studying parallel behaviors in humans and animal models. Curr Top Behav Neurosci 2013;13:611-45
- Addolorato G, Leggio L, Woodward Hopf F, et al. Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels, and transcranial magnetic stimulation. Neuropsychopharmacol Rev 2012;37:163-77
- Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol 2012;77:382-400
- Schank JR, Ryabinin AE, Giardino WJ, et al. Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron 2012;76:192-208
- Torregrossa MM, Taylor JR. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology (Berl) 2013;226:659-72